注射用拉氧头孢钠致严重肝功能异常1例分析

doi:10.19803/j.1672-8629.2021.10.22

中国药物警戒 ›› 2021, Vol. 18 ›› Issue (10): 992-994.
DOI: 10.19803/j.1672-8629.2021.10.22

注射用拉氧头孢钠致严重肝功能异常1例分析

李小丽^1,2, 陆璐¹, 邢晓璇¹, 董月鑫¹, 褚燕琦^1,*

¹首都医科大学宣武医院药学部,北京 100053;
²贵州省习水县人民医院药剂科,贵州习水 564600

收稿日期:2020-01-21 出版日期:2021-10-15 发布日期:2021-10-27
通讯作者: ^*褚燕琦,女,硕士,主任药师,临床药学与重症药学。E-mail：yanqi0545@sina.com
作者简介:李小丽,女,本科,药师,临床药学。

One Case of Severe Liver Dysfunction Induced by Latamoxef Sodium for Injection

LI Xiaoli^1,2, LU Lu¹, XING Xiaoxuan¹, DONG Yuexin¹, CHU Yanqi^1*

¹Department of Pharmacy, Xuanwu Hospital, Capital Medical University, Beijing 100053, China;
²Department of Pharmacy, Xishui County People's Hospital, Guizhou Province, Xishui Guizhou 564600, China

Received:2020-01-21 Online:2021-10-15 Published:2021-10-27

摘要/Abstract

摘要： 目的对1例注射用拉氧头孢钠致肝功能异常严重不良反应病例进行分析,为临床合理使用拉氧头孢钠提供参考。方法临床药师参与1例胆囊炎患者的药物治疗,通过筛查患者住院前后所用药物、诊疗经过查找肝损伤的原因,并采用药品不良反应（adverse drug reaction, ADR）关联性评价标准评估可能引起肝损伤的药物,最终确定导致肝功能异常的药物为注射用拉氧头孢钠,同时根据患者临床症状、实验室检查指标等先后建议加用谷胱甘肽保肝对症治疗;停用注射用拉氧头孢钠,改用头孢哌酮/舒巴坦钠抗感染治疗,并进行疗效评价、肝功能指标检测等药学监护。结果医师采纳临床药师建议;患者肝功能异常情况逐渐好转,腹部感染好转。结论在使用注射用拉氧头孢钠治疗过程中,医生应关注肝功能的变化,加强跟踪及用药监护,保证患者安全用药。

关键词: 拉氧头孢钠, 肝功能, 药品不良反应

Abstract: Objective To analyze one case of severe adverse reactions—liver damage caused by latamoxef sodium for injection in order to provide reference for rational use of latamoxef sodium. Methods A clinical pharmacist participated in the treatment of one patient with cholecystitis. The pharmacist screened the drugs used by this patient before and after hospitalization to find the cause of liver damage. The drugs that might have caused liver injury were evaluated by the relevance evaluation standard for adverse drug reactions (ADR). Finally, it was determined that the drug that caused abnormal liver function was latamoxef sodium for injection. According to the clinical symptoms and laboratory examination indexes of the patient, glutathione was added as a symptomatic therapy to protect the liver. Latamoxef sodium was replaced by efoperazone/sulbactam sodium as an anti-infection therapy, followed by efficacy evaluation of drugs and liver function index detection. Results Clinicians adopted the advice of the clinical pharmacist. The abnormal liver function and infection of the patient were gradually improved. Conclusion Clinicians ought to be alert to the changes of liver function when using latamoxef sodium for injection and do a better job of tracking and medication monitoring in order to ensure the safe use of drugs for patients.

Key words: latamoxef sodium for injection, liver function, adverse drug reaction

中图分类号:

R994.11

李小丽, 陆璐, 邢晓璇, 董月鑫, 褚燕琦. 注射用拉氧头孢钠致严重肝功能异常1例分析[J]. 中国药物警戒, 2021, 18(10): 992-994.

LI Xiaoli, LU Lu, XING Xiaoxuan, DONG Yuexin, CHU Yanqi. One Case of Severe Liver Dysfunction Induced by Latamoxef Sodium for Injection[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 992-994.

参考文献

[1] Dai HF, Huang ZR, Liao CL, et al.The effect of Laoxycephalosporin in the treatment of extended-spectrum β-lactamase Escherichia coli pneumonia in children[J]. China Contemporary Medicine(中国当代医药), 2019, 26(10): 122-124.
[2] Liang DC, Chen WY.The clinical characteristics and causes of adverse reactions to cephalosporins[J]. Beifang Pharmacy(北方药学),2019, 16(10): 173-174.
[3] Fan Zhenhua, Dun Xinyu.Vitamin K1 in the treatment of coagulation dysfunction caused by intravenous infusion of laoxef sodium for injection[J]. Health Must Read(健康必读), 2019 (16): 161-162.
[4] Li WX, Xu L, Zhao XY, et al.Clinical analysis of 52 cases of intracranial infection treated by Laoxycephalosporin[J]. China Journal of Modern Medicine(中国现代医药杂志), 2010, 12(7): 73-74.
[5] Pharmaceutical Hepatology Group, Chinese Medical Association Hepatology Branch. Guidelines for the diagnosis and treatment of drug-induced liver injury[J]. Chinese Journal of Hepatology(中华肝脏病杂志), 2015, 23(11): 810-820.
[6] Chalasani NP, Hayashi PH, Bonkovsky HL, et al.ACG clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury[J]. Am J Gastroenterol, 2014, 109(7): 950-966.
[7] Jia WP, Guo DH, Tian XY, et al, Analysis of 1110 cases of drug-induced liver injury adverse reactions/events in 79 hospitals[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2017, 14(8): 481-485.
[8] Liu JP, Xing JM.Evidence-based adverse drug reaction evaluation method[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2010, 7(1): 12-15.
[9] Yang MM, Ren J, Heng Y, et al.Discussion on the role of clinical pharmacists in the prevention and treatment of drug-induced liver injury[J]. China Pharmacy(中国药房), 2015, 26(2): 264-266.
[10] Ministry of Health of the People’s Republic of China. Measures for the Administration of Adverse Drug Reaction Reporting and Monitoring (Order No. 81 of the Ministry of Health)[EB/OL]. (2011-05-04) [2019-12-28]. http://www.gov.cn/gongbao/content/2011/content_2004739.htm.
[11] Wang MF.Analysis of adverse drug reactions and drug safety analysis of elderly clinical medicine[J]. Systems Medicine(系统医学), 2019, 4(8): 145-147.
[12] Li WF, Wang D.Clinical analysis of common adverse drug reactions and rational drug use in the elderly[J]. Chinese and Foreign Medical Sciences(中外医疗), 2019, 38(19): 19-21.
[13] Cui YX.Study on the characteristics and risk factors of adverse reactions caused by the use of antibiotics in elderly patients[J]. China Prescription Drugs(中国处方药), 2016, 14(7): 34-35.
[14] Ge JB, Xu YJ. Internal Medicine(内科学)[M]. 8 Ed. Beijing: People’s Medical Publishing House, 2014: 417.
[15] Mao JJ.A case of abnormal liver function caused by sodium valproate for injection[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(3): 191-192.

注射用拉氧头孢钠致严重肝功能异常1例分析

One Case of Severe Liver Dysfunction Induced by Latamoxef Sodium for Injection

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	贾晋生, 刘红亮, 王青, 侯永芳, 李馨龄. 基于知识图谱联合ERNIE-DPCNN模型的药品不良反应自动关联性评价方法研究[J]. 中国药物警戒, 2024, 21(2): 163-166.
[2]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[3]	徐伟佳, 彭崎, 黄海渝, 张磊姣, 肖华, 吴雪. 285例新型抗肿瘤药物不良反应分析[J]. 中国药物警戒, 2024, 21(2): 199-203.
[4]	郭清华, 彭笑笑, 朱萍, 刘西霖, 杨颖华, 陈志海. 氨氯地平过量致多器官功能障碍综合征1例分析[J]. 中国药物警戒, 2024, 21(2): 204-207.
[5]	方美琳, 郑慧敏, 王存泽, 王凌, 阮君山. 注射用奥沙利铂致全身肌肉疼痛1例分析[J]. 中国药物警戒, 2024, 21(2): 208-210.
[6]	陈玉艳, 张明霞, 张涛, 张晋. 斯鲁利单抗注射液致间质性肺炎不良反应1例分析[J]. 中国药物警戒, 2024, 21(2): 213-215.
[7]	曹桂萍, 邓琳琳, 朱干红, 陆颖, 马爽, 陈玲玲, 刘丽丽. 天麻首乌片致严重肝损伤1例分析[J]. 中国药物警戒, 2024, 21(2): 216-218.
[8]	高云娟, 赵旭, 白天凯, 柏兆方, 王伽伯, 宋海波, 肖小河. 基于不良反应监测大数据的药品安全风险发现与识别策略[J]. 中国药物警戒, 2024, 21(1): 1-5.
[9]	郭龙鑫, 高云娟, 吴承钊, 龙敏娟, 祝胜凯, 宋海波, 赵旭, 肖小河. 基于不良反应监测大数据的中药药源性肝损伤风险信号新发现及易感因素初探[J]. 中国药物警戒, 2024, 21(1): 15-19.
[10]	蒋文硕, 杨莉. 694例癫痫医师药师联合门诊患者药品不良反应分析[J]. 中国药物警戒, 2024, 21(1): 102-106.
[11]	陈华炎, 江东波, 郭春连, 杨家琪, 黎雨欣, 蔡伟明. 326例奈玛特韦片/利托那韦片治疗新型冠状病毒感染安全性分析[J]. 中国药物警戒, 2024, 21(1): 107-110.
[12]	刘赛月, 吕小琴, 周耘. 疑似药品不良反应死亡病例调查及报告实施要点[J]. 中国药物警戒, 2023, 20(9): 971-974.
[13]	里筱竹, 王蔷, 逄瑜, 张轶菁. 个例药品不良反应报告管理浅析与思考[J]. 中国药物警戒, 2023, 20(9): 975-977.
[14]	逄瑜, 刘博, 吕少俐, 王涛, 邢颖, 秦星宇, 田月洁, 吴文宇. 基于国际药物警戒经验探讨收集患者报告的意义[J]. 中国药物警戒, 2023, 20(9): 978-981.
[15]	刘文东, 崔欢欢, 王晓晗, 苏娴, 王海学. 我国儿童用药临床试验期间药物警戒监管体系现状及思考[J]. 中国药物警戒, 2023, 20(9): 1002-1006.